| mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
| mRNA |
Pazopanib |
FIMM |
pan-cancer |
AAC |
0.026 |
0.9 |
| mRNA |
Sorafenib |
FIMM |
pan-cancer |
AAC |
-0.024 |
0.9 |
| mRNA |
phenformin |
GDSC1000 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
| mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
| mRNA |
Cisplatin |
GDSC1000 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
| mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
| mRNA |
LFM-A13 |
GDSC1000 |
pan-cancer |
AAC |
0.0036 |
0.9 |
| mRNA |
Platin |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |